Octagon Capital Advisors LP
Octagon Capital invests in public and private healthcare companies globally.
Business Model:
Revenue: $0
Employees: 0-0
Rankings
Industries / Tags:
Detailed Octagon Capital Advisors LP Information
Geographic Data
Address:
City:
State:
Zip:
Country:
Financial Info
Stage:
Raised Last:
$0
Raised Total:$0
Social
Crunchbase
Metrics
4,048,346Website Global Rank
2,933Website Monthly Traffic
Twitter Followers
Description
Octagon Capital invests in public and private healthcare companies globally. Octagon Capital focuses on strategic long-term investments and strive to work with our portfolio management teams as partners.
Contact Phone:
Contact Email:
| Announced Date | Company | Transaction | Money Raised |
|---|---|---|---|
| 11/2021 | Allorion Therapeutics | Series A | 0 |
| 5/2021 | Vedere Bio ll | Series A | 0 |
| 12/2021 | AnHeart Therapeutics | Series B | 0 |
| 5/2021 | NiKang Therapeutics | Series C | 200M |
| 5/2021 | Hummingbird Bioscience | Series C | 0 |
| 3/2021 | Hanyu Medical | Series D | 76.9M |
| 11/2021 | Edge Medical Robotics | Series C | 0 |
| 3/2021 | Aktis Oncology | Series A | 72M |
| 3/2021 | StrideBio | Series B | 0 |
| 5/2021 | Affinia Therapeutics | Series B | 0 |
| 8/2022 | Aktis Oncology | Series A | 0 |
| 5/2021 | Numab | Series C | 110.6M |
| 4/2023 | Alebund Pharmaceuticals | Series C | 0 |
| 6/2021 | ArriVent Biopharma | Series A | 81M |
| 2/2022 | ArriVent Biopharma | Series A | 69M |
| 9/2021 | Alebund Pharmaceuticals | Series B | 0 |
| 12/2022 | ArriVent Biopharma | Series B | 0 |
| 8/2022 | Bluejay Therapeutics | Series B | 0 |
| 3/2021 | Immune-Onc Therapeutics | Series B | 0 |
| 4/2021 | Forge Biologics | Series B | 120M |
| 3/2021 | Arctic Vision | Series B | 0 |
| 2/2022 | ArriVent Biopharma | Series A | 0 |
| 12/2021 | AnHeart Therapeutics | Series B | 0 |
| 11/2021 | Allorion Therapeutics | Series A | 0 |
| 11/2021 | Edge Medical Robotics | Series C | 0 |
| 9/2021 | Alebund Pharmaceuticals | Series B | 0 |
| 6/2021 | ArriVent Biopharma | Series A | 0 |
| 5/2021 | NiKang Therapeutics | Series C | 0 |
| 5/2021 | Numab | Series C | 0 |
| 5/2021 | Vedere Bio ll | Series A | 0 |
| 5/2021 | Hummingbird Bioscience | Series C | 0 |
Startup Industries
Startup Locations
Portfolio Current Status
Portfolio Employee Count
| Name | Price |
|---|
| Name | Size | Announced Date |
|---|
